27 related articles for article (PubMed ID: 12866722)
21. Differential effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on plasma paraoxonase 1 activity in the rat.
Bełtowski J; Wójcicka G; Jamroz A
Pol J Pharmacol; 2002; 54(6):661-71. PubMed ID: 12866722
[TBL] [Abstract][Full Text] [Related]
22. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Istvan ES
Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413
[TBL] [Abstract][Full Text] [Related]
23. Benefits and difficulties in measuring HDL subfractions and human paraoxonase-1 activity during statin treatment.
Harangi M; Seres I; Harangi J; Paragh G
Cardiovasc Drugs Ther; 2009 Dec; 23(6):501-10. PubMed ID: 19859794
[TBL] [Abstract][Full Text] [Related]
24. Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials.
Ferretti G; Bacchetti T; Sahebkar A
Prog Lipid Res; 2015 Oct; 60():50-73. PubMed ID: 26416579
[TBL] [Abstract][Full Text] [Related]
25. [Paraoxonase: its multiple functions and pharmacological regulation].
Fridman O; Fuchs AG; Porcile R; Morales AV; Gariglio LO
Arch Cardiol Mex; 2011; 81(3):251-60. PubMed ID: 21975240
[TBL] [Abstract][Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
